About
Andrew Cappetta joined SV Health Investors in 2022 as an Associate on the Healthcare Growth Team and advanced to Senior Associate in 2024 and Vice President in 2025. Before SV, he worked on Thermo Fisher Scientific's Corporate Development team, focusing on M&A of healthcare and life science companies, where he executed two transactions totaling $550 million. He holds a B.S. in Business Administration: Finance from the University of New Hampshire.
Invests in
BiotechHealthtech
Colleagues at SV Health Investors
A.J. Rossi
Partner at SV Health Investors
Aaron Sandoski
MCF Partner at SV Health Investors
Alex Badamchi-Zadeh
Vice President at SV Health Investors
Brent Faduski
CFO, CCO and Partner at SV Health Investors
Charles Dunn
Principal at SV Health Investors
Christian Jung
Partner at SV Health Investors
Darren Black
Partner at SV Health Investors
Dirk Landgraf
Principal at SV Health Investors